UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ERBB2-MED1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ERBB2-MED1 | FusionPDB ID: 27173 | FusionGDB2.0 ID: 27173 | Hgene | Tgene | Gene symbol | ERBB2 | MED1 | Gene ID | 2064 | 8930 |
Gene name | erb-b2 receptor tyrosine kinase 2 | methyl-CpG binding domain 4, DNA glycosylase | |
Synonyms | CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 | MED1 | |
Cytomap | 17q12 | 3q21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | receptor tyrosine-protein kinase erbB-2c-erb B2/neu proteinherstatinhuman epidermal growth factor receptor 2metastatic lymph node gene 19 proteinneuro/glioblastoma derived oncogene homologneuroblastoma/glioblastoma derived oncogene homologp185erbB2 | methyl-CpG-binding domain protein 43,N(4)-ethenocytosine glycosylaseG/5-fluorouracil mismatch glycosylase with biphasic kineticsG/T mismatch glycosylaseG/U mismatch glycosylasemethyl-CpG binding domain protein 4methyl-CpG-binding endonuclease 1meth | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | P04626 | A0JLT2 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000269571, ENST00000406381, ENST00000445658, ENST00000540147, ENST00000541774, ENST00000578199, ENST00000584450, ENST00000584601, ENST00000540042, ENST00000584888, | ENST00000300651, ENST00000394287, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 50 X 44 X 14=30800 | 9 X 8 X 5=360 |
# samples | 73 | 10 | |
** MAII score | log2(73/30800*10)=-5.39889007670225 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/360*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ERBB2 [Title/Abstract] AND MED1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ERBB2(37873733)-MED1(37571592), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. ERBB2-MED1 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. ERBB2-MED1 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. ERBB2-MED1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ERBB2 | GO:0007165 | signal transduction | 10572067 |
Hgene | ERBB2 | GO:0007166 | cell surface receptor signaling pathway | 9685399 |
Hgene | ERBB2 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 7514177 |
Hgene | ERBB2 | GO:0014065 | phosphatidylinositol 3-kinase signaling | 7556068 |
Hgene | ERBB2 | GO:0018108 | peptidyl-tyrosine phosphorylation | 12000754 |
Hgene | ERBB2 | GO:0032886 | regulation of microtubule-based process | 20937854 |
Hgene | ERBB2 | GO:0035556 | intracellular signal transduction | 19372587 |
Hgene | ERBB2 | GO:0042060 | wound healing | 12646923 |
Hgene | ERBB2 | GO:0043406 | positive regulation of MAP kinase activity | 10572067 |
Hgene | ERBB2 | GO:0045785 | positive regulation of cell adhesion | 7556068 |
Hgene | ERBB2 | GO:0046777 | protein autophosphorylation | 7556068 |
Hgene | ERBB2 | GO:0050679 | positive regulation of epithelial cell proliferation | 10572067 |
Hgene | ERBB2 | GO:0071363 | cellular response to growth factor stimulus | 20010870 |
Hgene | ERBB2 | GO:0090314 | positive regulation of protein targeting to membrane | 20010870 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-D8-A1XJ-01A | ERBB2 | chr17 | 37873733 | + | MED1 | chr17 | 37571592 | - |
ChimerDB4 | BRCA | TCGA-D8-A1XJ | ERBB2 | chr17 | 37873733 | + | MED1 | chr17 | 37571592 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000540042 | ERBB2 | chr17 | 37873733 | + | ENST00000394287 | MED1 | chr17 | 37571592 | - | 3353 | 1986 | 166 | 1884 | 572 |
ENST00000540042 | ERBB2 | chr17 | 37873733 | + | ENST00000300651 | MED1 | chr17 | 37571592 | - | 6309 | 1986 | 1964 | 5434 | 1156 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000540042 | ENST00000394287 | ERBB2 | chr17 | 37873733 | + | MED1 | chr17 | 37571592 | - | 0.011840628 | 0.9881593 |
ENST00000540042 | ENST00000300651 | ERBB2 | chr17 | 37873733 | + | MED1 | chr17 | 37571592 | - | 0.007855075 | 0.9921449 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >27173_27173_1_ERBB2-MED1_ERBB2_chr17_37873733_ENST00000540042_MED1_chr17_37571592_ENST00000300651_length(amino acids)=1156AA_BP=8 MKYKLMPYSPGLLQFEVCPLSESRFSVSFQHPVNDSLVCVVMDVQDSTHVSCKLYKGLSDALICTDDFIAKVVQRCMSIPVTMRAIRRKA ETIQADTPALSLIAETVEDMVKKNLPPASSPGYGMTTGNNPMSGTTTPTNTFPGGPITTLFNMSMSIKDRHESVGHGEDFSKVSQNPILT SLLQITGNGGSTIGSSPTPPHHTPPPVSSMAGNTKNHPMLMNLLKDNPAQDFSTLYGSSPLERQNSSSGSPRMEICSGSNKTKKKKSSRL PPEKPKHQTEDDFQRELFSMDVDSQNPIFDVNMTADTLDTPHITPAPSQCSTPPTTYPQPVPHPQPSIQRMVRLSSSDSIGPDVTDILSD IAEEASKLPSTSDDCPAIGTPLRDSSSSGHSQSTLFDSDVFQTNNNENPYTDPADLIADAAGSPSSDSPTNHFFHDGVDFNPDLLNSQSQ SGFGEEYFDESSQSGDNDDFKGFASQALNTLGVPMLGGDNGETKFKGNNQADTVDFSIISVAGKALAPADLMEHHSGSQGPLLTTGDLGK EKTQKRVKEGNGTSNSTLSGPGLDSKPGKRSRTPSNDGKSKDKPPKRKKADTEGKSPSHSSSNRPFTPPTSTGGSKSPGSAGRSQTPPGV ATPPIPKITIQIPKGTVMVGKPSSHSQYTSSGSVSSSGSKSHHSHSSSSSSSASTSGKMKSSKSEGSSSSKLSSSMYSSQGSSGSSQSKN SSQSGGKPGSSPITKHGLSSGSSSTKMKPQGKPSSLMNPSLSKPNISPSHSRPPGGSDKLASPMKPVPGTPPSSKAKSPISSGSGGSHMS GTSSSSGMKSSSGLGSSGSLSQKTPPSSNSCTASSSSFSSSGSSMSSSQNQHGSSKGKSPSRNKKPSLTAVIDKLKHGVVTSGPGGEDPL DGQMGVSTNSSSHPMSSKHNMSGGEFQGKREKSDKDKSKVSTSGSSVDSSKKTSESKNVGSTGVAKIIISKHDGGSPSIKAKVTLQKPGE SSGEGLRPQMASSKNYGSPLISGSTPKHERGSPSHSKSPAYTPQNLDSESESGSSIAEKSYQNSPSSDDGIRPLPEYSTEKHKKHKKEKK -------------------------------------------------------------- >27173_27173_2_ERBB2-MED1_ERBB2_chr17_37873733_ENST00000540042_MED1_chr17_37571592_ENST00000394287_length(amino acids)=572AA_BP= MKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNG DPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSE DCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACP YNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTA PLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTV PWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQ -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:37873733/chr17:37571592) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ERBB2 | MED1 |
FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}. | FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 1078_1482 | 432.3333333333333 | 1582.0 | Compositional bias | Note=Ser-rich | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 1496_1529 | 432.3333333333333 | 1582.0 | Compositional bias | Note=Lys-rich | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 1078_1482 | 432.3333333333333 | 557.0 | Compositional bias | Note=Ser-rich | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 1496_1529 | 432.3333333333333 | 557.0 | Compositional bias | Note=Lys-rich | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 604_608 | 432.3333333333333 | 1582.0 | Motif | Note=LXXLL motif 1 | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 645_649 | 432.3333333333333 | 1582.0 | Motif | Note=LXXLL motif 2 | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 875_902 | 432.3333333333333 | 1582.0 | Motif | Integrase domain-binding motif (IBM) | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 604_608 | 432.3333333333333 | 557.0 | Motif | Note=LXXLL motif 1 | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 645_649 | 432.3333333333333 | 557.0 | Motif | Note=LXXLL motif 2 | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 875_902 | 432.3333333333333 | 557.0 | Motif | Integrase domain-binding motif (IBM) |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 720_987 | 632.6666666666666 | 1256.0 | Domain | Protein kinase |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 720_987 | 617.6666666666666 | 1241.0 | Domain | Protein kinase |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 676_689 | 632.6666666666666 | 1256.0 | Motif | Note=Nuclear localization signal |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 676_689 | 617.6666666666666 | 1241.0 | Motif | Note=Nuclear localization signal |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 726_734 | 632.6666666666666 | 1256.0 | Nucleotide binding | ATP |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 726_734 | 617.6666666666666 | 1241.0 | Nucleotide binding | ATP |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 23_652 | 632.6666666666666 | 1256.0 | Topological domain | Extracellular |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 676_1255 | 632.6666666666666 | 1256.0 | Topological domain | Cytoplasmic |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 23_652 | 617.6666666666666 | 1241.0 | Topological domain | Extracellular |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 676_1255 | 617.6666666666666 | 1241.0 | Topological domain | Cytoplasmic |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 653_675 | 632.6666666666666 | 1256.0 | Transmembrane | Helical |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 653_675 | 617.6666666666666 | 1241.0 | Transmembrane | Helical |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>1894_ERBB2_37873733_MED1_37571592_ranked_0.pdb | ERBB2 | 37873733 | 37873733 | ENST00000300651 | MED1 | chr17 | 37571592 | - | MKYKLMPYSPGLLQFEVCPLSESRFSVSFQHPVNDSLVCVVMDVQDSTHVSCKLYKGLSDALICTDDFIAKVVQRCMSIPVTMRAIRRKA ETIQADTPALSLIAETVEDMVKKNLPPASSPGYGMTTGNNPMSGTTTPTNTFPGGPITTLFNMSMSIKDRHESVGHGEDFSKVSQNPILT SLLQITGNGGSTIGSSPTPPHHTPPPVSSMAGNTKNHPMLMNLLKDNPAQDFSTLYGSSPLERQNSSSGSPRMEICSGSNKTKKKKSSRL PPEKPKHQTEDDFQRELFSMDVDSQNPIFDVNMTADTLDTPHITPAPSQCSTPPTTYPQPVPHPQPSIQRMVRLSSSDSIGPDVTDILSD IAEEASKLPSTSDDCPAIGTPLRDSSSSGHSQSTLFDSDVFQTNNNENPYTDPADLIADAAGSPSSDSPTNHFFHDGVDFNPDLLNSQSQ SGFGEEYFDESSQSGDNDDFKGFASQALNTLGVPMLGGDNGETKFKGNNQADTVDFSIISVAGKALAPADLMEHHSGSQGPLLTTGDLGK EKTQKRVKEGNGTSNSTLSGPGLDSKPGKRSRTPSNDGKSKDKPPKRKKADTEGKSPSHSSSNRPFTPPTSTGGSKSPGSAGRSQTPPGV ATPPIPKITIQIPKGTVMVGKPSSHSQYTSSGSVSSSGSKSHHSHSSSSSSSASTSGKMKSSKSEGSSSSKLSSSMYSSQGSSGSSQSKN SSQSGGKPGSSPITKHGLSSGSSSTKMKPQGKPSSLMNPSLSKPNISPSHSRPPGGSDKLASPMKPVPGTPPSSKAKSPISSGSGGSHMS GTSSSSGMKSSSGLGSSGSLSQKTPPSSNSCTASSSSFSSSGSSMSSSQNQHGSSKGKSPSRNKKPSLTAVIDKLKHGVVTSGPGGEDPL DGQMGVSTNSSSHPMSSKHNMSGGEFQGKREKSDKDKSKVSTSGSSVDSSKKTSESKNVGSTGVAKIIISKHDGGSPSIKAKVTLQKPGE SSGEGLRPQMASSKNYGSPLISGSTPKHERGSPSHSKSPAYTPQNLDSESESGSSIAEKSYQNSPSSDDGIRPLPEYSTEKHKKHKKEKK | 1156 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
ERBB2_pLDDT.png![]() |
MED1_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ERBB2 | |
MED1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000269571 | + | 15 | 27 | 1195_1197 | 632.6666666666666 | 1256.0 | PIK3C2B |
Hgene | ERBB2 | chr17:37873733 | chr17:37571592 | ENST00000541774 | + | 15 | 27 | 1195_1197 | 617.6666666666666 | 1241.0 | PIK3C2B |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 16_590 | 432.3333333333333 | 1582.0 | ESR1 | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 16_590 | 432.3333333333333 | 557.0 | ESR1 | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 108_212 | 432.3333333333333 | 1582.0 | the Mediator complex | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 215_390 | 432.3333333333333 | 1582.0 | the Mediator complex | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 108_212 | 432.3333333333333 | 557.0 | the Mediator complex | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 215_390 | 432.3333333333333 | 557.0 | the Mediator complex | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 1_670 | 432.3333333333333 | 1582.0 | the Mediator complex and THRA | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 1_670 | 432.3333333333333 | 557.0 | the Mediator complex and THRA | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000300651 | 13 | 17 | 405_644 | 432.3333333333333 | 1582.0 | THRA | |
Tgene | MED1 | chr17:37873733 | chr17:37571592 | ENST00000394287 | 13 | 18 | 405_644 | 432.3333333333333 | 557.0 | THRA |
Top |
Related Drugs to ERBB2-MED1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ERBB2-MED1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |